liquidia.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi LQDA
Liquidia Corporation (LQDA) management is flexibly adapting its strategy due to prolonged patent litigation, which supports the baseline EBITDA, where the current mark is 294.88. The business relies on the protection of rights within the field of inhalation therapy for pulmonary pathologies. High dosing precision is ensured here by the PRINT digital system, which eliminates personnel errors during the creation of drug microparticles.
Ringkesan rincian data analitis Liquidia (LQDA)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Liquidia Corporation|LQDA - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Liquidia Corp|LQDA - Gunggung utang perusahaan|Utang-utang marang aset resik Liquidia|LQDA - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Liquidia|Rasio cepet liquidia.com
- statistik bathi lan rasio pasar:
LQDA - Bathi resik|Prakiraan bathi perusahaan Liquidia Corporation|LQDA - Pangali P/E|Rasio rega marang bathi mangsa ngarep liquidia.com|LQDA - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Liquidia|LQDA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Liquidia|LQDA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan liquidia.com|LQDA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Liquidia Corporation
Ringkesan analitik perusahaan:LQDA Liquidia Inc.
To assess asset quality, an investor must analyze a business's ability to generate capital before taxes and interest payments, which reflects the actual efficiency of operational processes. By analyzing EBITDA in monetary terms, one can determine the speed at which Liquidia Corporation (LQDA) adapts to external shocks amid patent disputes and a focus on bringing the drug to market without utilizing M&A resources.
Pesaing Liquidia Corporation (LQDA)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|GLPG (glpg.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ANI Pharmaceuticals, Inc. ANIP|MannKind Corp - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Amphastar - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Pacira Corp PCRX|ARS Pharmaceuticals (SPRY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge potongan amortisasi theravance.com TBPH|Bathi operasional sadurunge ngurangi amortisasi AQST|Bathi operasional EBITDA scPharma|Bathi operasional EBITDA TECX|Pendapatan operasional sadurunge ngurangi amortisasi Tonix Pharmaceuticals Holding|Bathi operasional EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|EPRX: Bathi operasional sadurunge amortisasi|BioHarvest Sciences Inc. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Invizyne Technologies EXOZ|ORMP: Bathi operasional EBITDA|Entera Bio (ENTX) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi HYFT|ABVC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA CPIX|Bathi operasional sadurunge ngurangi amortisasi Quantum BioPharma Ltd. QNTM|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FibroGen Corp FGEN|Telomir Pharmaceuticals Corp (TELO) - Bathi sadurunge bunga, pajak, lan amortisasi|RANI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi LEXX (Lexaria Bioscience Corp.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pulmatrix Corp|Bathi sadurunge bunga, pajak, lan amortisasi Pheton PTHL|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA IBO (Impact BioMedical)|Bathi operasional EBITDA TNF Pharmaceuticals Inc. TNFA|YCBD: Bathi operasional sadurunge ngurangi amortisasi|PainReform Corp - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CYTO: Bathi operasional EBITDA|LIPO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OptiNose|Bathi sadurunge bunga, pajak, lan amortisasi Pieris Pharmaceuticals Inc PIRS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Petros Pharma - Bathi operasional sadurunge amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International QLI|acelyrin.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TFFP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi
